Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (5): 510-513.doi: 10.3736/jcim20070506

Special Issue: Traditional Chinese Medicine

• Original Clinical Research • Previous Articles     Next Articles

Multifactor analysis of syndrome differentiation in traditional Chinese medicine and clinical correlative factors in gastric cancer

Li Tao, Jin-kun Yang   

  1. First Department of Tumor , Longhua Hospital ,Shanghai University of Traditional Chinese Medicine , Shanghai 200032,China
  • Online:2007-09-20 Published:2007-09-15

Objective: The research is aimed at investigating the developing rule and the relationship between syndrome differentiation in traditional Chinese Medicine (TCM) and clinical factors of gastric cancer so as to guide clinical work and indicate prognosis.Methods: We collected the medical records and the information of four diagnostic methods of 325 cases of gastric cancer sufferers in the way of clinical epidemiological survey, and divided them into 6 syndromes including dysfunction of spleen, disharmony of liver and stomach, blood stagnation in stomach, yin deficiency of stomach, phlegm dampness stagnation and deficiency of both qi and blood. Then we used logistic regression analysis to analyze the relationship between syndrome differentiation and clinical-related factors such as age, gender, Karnofsky score and clinical stage, etc.Results: The syndrome spleen dysfunction is a dominant one among the syndromes of stomach cancer. Disharmony of liver and stomach always happens in early stage of stomach cancer and is frequently seen in women. Patients with syndrome of phlegm dampness stagnation or deficiency of both qi and blood have lower Karnofsky score and poorer living quality. Syndromes of blood stagnation in stomach and yin deficiency of stomach show no relationship with the clinical factors in this research.Conclusion: >Syndrome differentiation in TCM of gastric cancer is related to some clinical factors to a certain extent.

Key words: gastric cancer, traditional Chinese medicine, clinical factor, logistic regression analysis

CLC Number: 

  • R735.2

Table 1

Logistic regression analysis of dysfunction of spleen"

Variable B Std. Error Wald Sig Exp (B)
KPS score –0.118 0.026 19.990 0.000 0.889
Suffering time –0.135 0.450 0.090 0.764 0.874
Surgical mode 1.697 1.865 0.828 0.363 5.459
Course of chemotherapy 0.181 0.291 0.388 0.533 1.199
Metastasis –5.700 3.177 3.220 0.073 0.003

Table 2

Logistic regression analysis of disharmony of liver and stomach"

Variable B Std. Error Wald Sig Exp (B)
Sex –0.834 0.419 3.958 0.047 0.434
Clinical stage 0.694 0.245 8.005 0.005 2.002
Surgical mode 14.797 3 035.240 0.000 0.996 2 668 188.125
Metastasis 13.238 3 762.011 0.000 0.997 561 166.319

Table 3

Logistic regression analysis of blood stagnation in stomach"

Variable B Std. Error Wald Sig Exp (B)
KPS score 0.045 0.087 0.266 0.606 1.046
Clinical stage –1.385 1.631 0.721 0.396 0.250
Surgical mode –0.121 20 943.250 0.000 1.000 0.886
Suffering time 16.063 5 551.222 0.000 0.998 9 461 739
Metastasis 19.607 34 756.010 0.000 1.000 330 000 000

Table 4

Logistic regression analysis of phlegm dampness stagnation"

Variable B Std. Error Wald Sig Exp (B)
KPS score 0.031 0.015 4.180 0.041 1.032
Clinical stage –0.295 0.219 1.810 0.178 0.745

Table 5

Logistic regression analysis of deficiency of qi and blood"

Variable B Std. Error Wald Sig Exp (B)
KPS score 0.240 0.101 5.640 0.018 1.272
Clinical stage –1.388 5.375 0.067 0.796 0.249
Surgical mode –5.070 4.178 1.473 0.225 0.006
Course of chemotherapy –1.432 2.044 0.491 0.483 0.239
Suffering time 13.838 5 036.177 0.000 0.998 1 022 294
Relapse 0.052 35.530 0.000 0.999 1.053
Metastasis 7.950 8.065 0.972 0.324 2 835.003
[1] 中国抗癌协会. 新编常见恶性肿瘤诊治规范[M]. 北京: 中国协和医科大学出版社,1999 1-94
Chinese Anti-cancer Association . New criteria for diagnosis and treatment of common malignant tumors[M]. Beijing: Beijing Union Medical University Press,1999 1-94
[2] 陶丽, 杨金坤 . 胃癌中医辨证分型的文献分析[J]. 中医药学刊, 2006,24(4):684-686
Tao L, Yang JK . Analysis on the literature about syndrome differentiation of gastric cancer in traditional Chinese medicine[J]. Zhong Yi Yao Xue Kan, 2006,24(4):684-686
[3] 国家技术监督局. 中华人民共和国国家标准·中医临床诊疗术语证候部分[M]. 北京: 中国标准出版社,1997 1-38
The State Bureau of Technology Supervision. National Standards of People's Republic of China: Syndrome part of terminology of traditional Chinese medicine clinical diagnosis and treatment[M]. Beijing: Standards Press of China,1997 1-38
[4] 中华人民共和国卫生部. 中药新药临床研究指导原则(第三辑). 1997: 78-81.
Ministry of Health of the People's Republic of China. Guiding principle of clinical research on new drugs. Part 3. 1997: 78-81. Chinese.
[5] 上海市卫生局. 上海市中医病证诊疗常规(第2版)[M]. 上海: 上海中医药大学出版社, 2003,( 第2版):129-131
Shanghai Municipal Health Bureau . Criteria for diagnosis and treatment of traditional Chinese medicine syndromes in Shanghai(2nd ed)[M]. Shanghai: Shanghai University of Traditional Chinese Medicine Press, 2003,( 2nd ed):129-131
[6] 中国中医研究院广安门医院. 中医诊疗常规[M]. 北京: 中医古籍出版社,1989 297-299
Guang'anmen Hospital affiliated to China Academy of Traditional Chinese Medicine. Criteria for traditional Chinese medicine diagnosis and treatment[M]. Beijing: Publishing House of Ancient Books of Traditional Chinese Medicine,1989 297-299
[7] 邓铁涛, 郭振球 . 中医诊断学(第5版)[M]. 上海: 上海科学技术出版社,1984,(第5版):114- 117, 124-128
Deng TT, Guo ZQ.Traditional Chinese medicine diagnostics( 5th ed) [M].Shanghai: Shanghai Scientific and Technical Publishers , 1984,( 5th ed):114- 117, 124-128
[8] 陶丽, 杨金坤 . 胃癌中医证型与临床相关因素的单因素分析[J]. 中西医结合学报, 2007,5(4):398-402
Tao L, Yang JK . Univariate analysis of syndrome differentiation in traditional Chinese medicine and clinical correlative factors in gastric cancer[J]. Zhong Xi Yi Jie He Xue Bao, 2007,5(4):398-402
[1] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[2] Xue-qing Yu, Shu-guang Yang, Yang Xie, Jian-sheng Li. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of exploratory trial. Journal of Integrative Medicine, 2020, 18(2): 163-168.
[3] Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine, 2020, 18(2): 87-88.
[4] Wen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, Zhi Xiong Gerard Low, Xueling Sim, Foong Fong Mary Chong, Norbert Ludwig Wagner. Factors influencing communication of traditional Chinese medicine use between patients and doctors: a multisite cross-sectional study. Journal of Integrative Medicine, 2019, 17(6): 396-403.
[5] Mikhail Teppone. Medicine has always been “Modern” and “Scientific” from ancient times to the present day. Journal of Integrative Medicine, 2019, 17(4): 229-237.
[6] Charles Dalcanale Tesser, Ari Ojeda Ocampo Moré, Melissa Costa Santos, Emiliana Domingues Cunha da Silva, Fátima Terezinha Pelachini Farias, Lúcio José Botelho. Auriculotherapy in primary health care: A large-scale educational experience in Brazil. Journal of Integrative Medicine, 2019, 17(4): 302-309.
[7] Rachael Farrington, Ian F.Musgrave, Roger W.Byard. Evidence for the efficacy and safety of herbal weight loss preparations. Journal of Integrative Medicine, 2019, 17(2): 87-92.
[8] Fung-Kei Cheng. An overview of the contribution of acupuncture to thyroid disorders. Journal of Integrative Medicine, 2018, 16(6): 375-383.
[9] Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.
[10] Qing Ji, Yun-quan Luo, Wen-hai Wang, Xuan Liu, Qi Li, Shi-bing Su. Research advances in traditional Chinese medicine syndromes in cancer patients. Journal of Integrative Medicine, 2016, 14(1): 12-21.
[11] Bing He, Ge Zhang, Ai-ping Lu. Integrative network analysis: Bridging the gap between Western medicine and traditional Chinese medicine. Journal of Integrative Medicine, 2015, 13(3): 133-135.
[12] Zhao-guo Li, Xi-ru Liu. Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine: Diseases of Paediatrics (Part 3). Journal of Integrative Medicine, 2015, 13(3): 201-204.
[13] Xiao Ye, Jing Wang. On English translation of infant Tuina points in traditional Chinese medicine. Journal of Integrative Medicine, 2015, 13(3): 205-207.
[14] Zhao-guo Li. Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine: Diseases of Paediatrics (Part 2). Journal of Integrative Medicine, 2015, 13(2): 129-132.
[15] Zhao-guo Li . Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine: Diseases of Paediatrics (Part 1). Journal of Integrative Medicine, 2015, 13(1): 61-64.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[4] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[6] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[7] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[8] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[9] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[10] Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079